BTMD Stock Analysis: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$2.29
-0.03 (-1.29%)
▼
5d:
+1.78%
30d:
-5.76%
90d:
+27.93%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
21d
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BTMD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: BTMD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.28
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$2.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $2.29, which is considered slightly high relative to its 30-day fair value range of $2.01 to $2.38. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.1) compared to its historical average (3.2). At these levels, the market is pricing in 8.7% annual earnings growth.
Technical Outlook: Technically, BTMD is in a uptrend. Immediate support is located at $1.63, while resistance sits at $2.40.
Market Sentiment: BTMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.99 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BTMD is in a uptrend. Immediate support is located at $1.63, while resistance sits at $2.40.
Market Sentiment: BTMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.99 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.01 -
$2.38
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.7% below Wall St target ($2.99)
- BULLISH: Expecting earnings turnaround to 8.7% growth with -8.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$2.01 -
$2.38
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.63
Resistance Level
$2.40
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.07
Wall Street Target
$2.99
(+28.7%)
Revenue Growth (YoY)
-8.3%
Earnings Growth (YoY)
-83.8%
Profit Margin
8.3%
Valuation Premium vs History
+8.7% premium
PE vs Historical
4.1 vs 3.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.7%
(market-implied from PE analysis)
1-Year Target
$2.52
(+9%)
2-Year Target
$2.74
(+18%)
3-Year Target
$2.98
(+28%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$2.34
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 21.3%)
$22.14
(+855%)
Base:
(SPY PE: 4.1, Growth: 21.3%)
$4.14
(+78%)
Bear:
(PE: 3.2, Growth: 21.3%)
$3.25
(+40%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (5x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 5.47 | Current EPS (TTM): $0.43
Bull Case
$3.43
(+48%)
Analyst growth 32.6%, PE expands to 6.0
Base Case
$3.12
(+34%)
Market implied 32.6%, PE stable at 5.5
Bear Case
$1.60
(-31%)
Severe decline -20.0%, PE contracts to 4.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 14, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
Data refreshes hourly during market hours. Next update: 12:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |
